Inmedix

Normandy Park, WA · Founded 2017 · Privately Held (backing)

Developer of a medical technology designed to assess autonomic nervous system function with clinical precision. Inmedix is based in Normandy Park, WA and was founded in 2017. It was valued at $33.5 million at its later-stage round in Nov 2024, the last priced event on record. It has raised $16.3 million across 3 recorded rounds; the latest was a $720,000 seed round in Aug 2024.

PMV mark · valuation
$33.5M
Oct 2026
Priced at
its later-stage round
Nov 2024
Total raised
$16.3M
Last round
Seed Round
Aug 2024
What is Inmedix worth?
$33.5MPrivateMarketView mark · Oct 2026

Valued at $33.5M at its later-stage round, Nov 2024. Nothing has traded since.

Free account
More of Inmedix with a free account
  • ·Watch Inmedix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Inmedix funding history

3 rounds
DateRoundRaisedPost-money
Aug 2024Seed Round$720K▮
Mar 2022Seed Round$445K▮
Mar 2021Debt$470K▮
Unlock post-money valuations

Membership and data by Private Market View

Inmedix valuation

Inmedix was valued at $33.5 million at its later-stage round in Nov 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inmedix raised?

Inmedix has raised $16.3 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $720,000 seed round in Aug 2024.

Inmedix has filed 5 Form Ds with the SEC since 2021, most recently in Oct 2025 ($159,980 sold to 4 investors).

How Inmedix's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Inmedix, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Inmedix

What is Inmedix worth?
Inmedix is valued at $33.5M as of Oct 2026. Valued at $33.5M at its later-stage round, Nov 2024. Nothing has traded since.
How much has Inmedix raised?
Inmedix has raised $16.3M in total funding across 3 recorded rounds.
When did Inmedix last raise?
Inmedix last raised in Aug 2024 (Seed Round), raising $720K.